Paradigm Health

About Paradigm Health

Paradigm Health is a company focused on transforming clinical research by orienting trials around patient care. Their mission is to build a future where clinical research is more viable and valuable for patients, providers, and trial sponsors through an intelligent research platform that fosters collaboration and empowerment.

Products & Services

Solutions for Providers:A service integrating technology to support health providers in clinical trials with crucial insights and collaboration.

Solutions for Sponsors:A service designed to assist trial sponsors in developing and delivering innovative therapies by connecting stakeholders and overcoming complexities.

Specialties

Clinical Research Patient-Centric Trials Healthcare Technology Integration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 78000000 MR: - FA: $78 million FAN: 78000000	D: 2025-12-04 FD: 2025-12-04	8 investors

Series B Latest

2025-12-04

$78.0M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kent Thoelke

Chief Executive Officer

J

Jonathan Hirsch

Chief Strategy & Growth Officer

J

Jay Trepanier

Chief Financial Officer

E

Elijah Meerson

Chief Technology Officer

M

Michelle Lee

Chief Operating Officer

P

Paul Kluetz

Chief Medical Officer

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

Paradigm Health Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised